WO 2008/104532 A1 - Topical Composition Comprising Fluocinolone Acetonide For Use In Depigmentation Of The Skin - The Lens

Topical Composition Comprising Fluocinolone Acetonide For Use In Depigmentation Of The Skin

Published: Sep 4, 2008
Earliest Priority: Feb 26 2007
Family: 6
Cited Works: 4
Cited by: 1
Cites: 3
Additional Info: Cited Works Full text

Abstract

The invention relates to a topical composition for depigmentation of the skin, comprising fluocinolone acetonide as depigmenting agent, at a concentration of between 0.0001% and 0.02% by weight, of the total weight of the composition, and a physiologically acceptable carrier.

Claims

Topical composition for depigmentation of the skin, comprising fluocinolone acetonide as depigmenting agent and a physiologically acceptable carrier, characterized in that the concentration of fluocinolone acetonide is between 0.0001% and 0.02% by weight, of the total weight of the composition.
Composition according to Claim 1, characterized in that it comprises neither hydroquinone nor tretinoin.
Composition according to Claim 1 or 2, characterized in that the concentration of fluocinolone acetonide is between 0.0005% and 0.01% by weight, of the total weight of the composition.
Composition according to either of Claims 1, 2 or 3, characterized in that it also comprises at least one sunscreen.
Composition according to any one of Claims 1 to 4, as a medicament.
Composition according to any one of Claims 1 to 5, as a cosmetic product.
Use of a composition according to Claim 6, for whitening the skin.
Use of a composition according to Claim 6, for protecting the skin against the harmful effects of sunlight .
Use of a composition according to Claim 5, in the manufacture of a medicament for use in the treatment and/or prevention of skin pigmentation disorders.
Use of a composition according to Claim 9, in the manufacture of a medicament for use in the treatment and/or prevention of melasma, chloasma, lentigines, senile lentigo, post-inflammatory hyperpigmentations due to abrasion and/or burns and/or scars and/or dermatosis and/or contact allergy and/or an irritant treatment; freckles, ephelides, planar pigmented seborrhoeic warts, naevi, genetically determined hyper¬ pigmentations, hyperpigmentations of metabolic or drug- related origin, or any other hyperpigmentary lesions, in particular those induced by photo-induced or chronological ageing of the skin and of the integuments .
Use of a composition according to Claim 9, in the manufacture of a medicament for use in the treatment and/or prevention of melasma.
Non-therapeutic cosmetic treatment process for embellishing the skin or its surface appearance, in which a composition comprising fluocinolone acetonide as depigmenting agent at a concentration of between
0001% and 0.02% by weight of the total weight of the composition and a physiologically acceptable carrier, is applied to the skin and/or its integuments.